Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Huperzine A is a naturally occurring compound extracted from the Chinese club moss Huperzia serrata. Its primary mechanism of action is as an acetylcholinesterase inhibitor, which means it prevents the breakdown of acetylcholine, an important neurotransmitter involved in memory and cognition. This property has prompted research into its potential to support or treat cognitive impairment, including "cloudy" thinking, mild cognitive impairment, and even Alzheimer's disease.

Several small-scale clinical trials, primarily conducted in China, have shown that huperzine A may improve cognitive function in individuals with memory deficits and dementia. For example, a 2013 meta-analysis published in PLOS ONE reviewed randomized controlled trials and found that huperzine A produced modest improvements in cognitive function, daily living activities, and global clinical assessment in patients with Alzheimer's disease when compared to placebo. However, the methodological quality of many of these studies was limited, and larger, high-quality trials are needed.

In healthy individuals, some evidence suggests huperzine A may enhance memory and learning, although the effects are generally mild and more research is required to establish its efficacy and safety in this population.

In summary, huperzine A has a scientific basis for use in supporting cognitive function and addressing "cloudy" thinking, especially in the context of cognitive impairment, but the quality and quantity of evidence are moderate, not robust. Its use should be considered experimental outside of clinical settings, with attention to possible side effects and contraindications.

More about huperzine A
More about Thinking (cloudy)

Other ingredients used for Thinking (cloudy)

Other health conditions supported by huperzine A

Products containing huperzine A